FDA urges drug makers to establish risk management plans to reduce drug shortages Managing supply chain risks is prudent, even if not enforceable by FDA | Hogan Lovells
Background FDA acknowledged in the press release announcing the draft guidance that disruptions in the U.S. drug supply continue to occur due to drug quality...

